Is there a role of a small dose of XXXX in the treatment of @entity8822 ?

@entity1 @entity8822 @entity2900 @entity1875
BACKGROUND: @entity1875 has been found to depress the laryngeal reflexes. We studied whether this property could be utilized to relieve @entity8822 . METHODS: This study was conducted over a period of 3 years, and included @entity1 aged 3-10 years, ASA status I and II. Most of the @entity1 were undergoing minor surgical procedures, under general anaesthesia with Laryngeal Mask Airway (LMA trade mark ) and caudal epidural analgesia. RESULTS: During this period, 20 @entity1 developed @entity8822 on removal of the LMA at the end of surgery. Initially, they all were treated with 100% O2, with gentle positive pressure ventilation. Out of 20 @entity1 , seven responded well with 100% O2 and gentle positive pressure ventilation. The remaining 13 were treated with a small dose of @entity1875 (0.8 mg.kg-1 body weight). @entity8822 was relieved successfully in 10 @entity1 and three @entity1 required intubation to improve their oxygenation. CONCLUSIONS: @entity1875 in a small dose (0.8 mg.kg-1 body weight) was a useful drug to relieve @entity8822 in most @entity1 (76.9%) following the removal of the LMA. Because it was not found to be effective in all @entity1 , @entity2900 still has a role to play in critical conditions. However, we recommend @entity1875 as a suitable alternative for relieving @entity8822 in situations where @entity2900 is contraindicated.
